Malawi has emerged as a beacon of public health commitment and efficiency, successfully executing two major vaccination initiatives in 2025 aimed at protecting its population and bolstering its health security. Through a comprehensive review meeting in December, the nation celebrated the impressive achievements of its Human Papillomavirus (HPV) vaccination campaign and its rapid, effective response to an Mpox outbreak. These successes highlight Malawi's growing capacity to implement critical health interventions and plan for a healthier future. ## Tackling Cervical Cancer: Malawi's HPV Vaccination Drive Cervical cancer, primarily caused by the Human Papillomavirus (HPV), remains a devastating disease, particularly in low-income countries where access to screening and treatment is limited. For many women in nations like Malawi, cervical cancer is a leading cause of cancer-related deaths, making preventative vaccination critically important. Recognizing this urgent need, Malawi's Ministry of Health launched a groundbreaking nationwide HPV Multi-Age Cohort (MAC) campaign in October 2025. This strategic campaign targeted a broad age range of girls, from 9 to 18 years old. The multi-age approach was crucial for closing existing coverage gaps, ensuring that older adolescent girls who might have missed earlier vaccination opportunities were also protected. A significant innovation in this campaign was the transition to a single-dose HPV vaccine schedule for 9-year-olds. This shift, supported by growing global evidence, simplifies vaccine delivery, reduces logistical challenges, and can significantly increase uptake and completion rates, making it a powerful tool in accelerating progress toward cervical cancer elimination targets set by the World Health Organization (WHO). The results were exceptional: the campaign achieved an impressive 91% coverage among the targeted adolescent girls. This high uptake not only provides vital protection against future cervical cancer but also marks a significant milestone in Malawi's commitment to health equity and disease prevention. By protecting its young female population, Malawi is laying the groundwork for a future with a drastically reduced burden of cervical cancer, aligning with global efforts to eliminate this preventable disease. ## Swift Action Against Mpox: A Model Outbreak Response While the HPV campaign focused on long-term prevention, Malawi also demonstrated its agility in reactive public health, responding decisively to an Mpox (formerly Monkeypox) outbreak declared in April 2025. Mpox, a viral disease characterized by a rash, fever, and flu-like symptoms, garnered global attention in 2022 when it spread rapidly outside of endemic regions, emphasizing the need for quick and effective outbreak control measures. Vaccination plays a critical role in containing such outbreaks. With crucial support from international partners, Malawi quickly introduced the Mpox vaccine. The strategy was two-pronged: offering both pre-exposure protection for high-risk individuals and post-exposure protection for those who had been in close contact with confirmed cases. This targeted approach is essential for maximizing the impact of limited vaccine supplies and controlling spread efficiently. A reactive vaccination campaign was swiftly implemented in October, deploying 33,605 doses across 12 priority districts that were most affected by the outbreak or deemed at highest risk. This campaign achieved extraordinary results: 100% coverage in the targeted populations with zero vaccine wastage. This remarkable success was not accidental; it was the result of meticulous planning, robust cold chain management to ensure vaccine viability, and highly adaptive delivery strategies. Mobile outreach teams played a crucial role, reaching high-risk communities quickly and effectively, overcoming geographical barriers and ensuring equitable access to the vaccine. Malawi’s Mpox response serves as a powerful example of how coordinated effort and strategic implementation can lead to swift and comprehensive containment of an infectious disease outbreak. ## The Foundation of Health: Strengthening Routine Immunization Beyond these targeted campaigns, Malawi's broader commitment to public health is anchored in the continuous strengthening of its routine immunization programs. Routine immunization is the backbone of any strong health system, providing essential protection against a wide array of preventable diseases from childhood through adulthood. The infrastructure, trained personnel, and community trust built through routine immunization programs are invaluable assets, directly contributing to the success of special campaigns like those for HPV and Mpox. The experiences gained from the HPV and Mpox campaigns – particularly in areas like vaccine logistics, cold chain maintenance, community engagement, and data management – directly feed back into and enhance the routine immunization system. By successfully delivering vaccines for specific diseases, health workers gain experience, supply chains are optimized, and public confidence in vaccination is reinforced. This integrated approach ensures that investments in one area of immunization contribute to the overall resilience and capacity of the national health system, preparing Malawi for future health challenges and ensuring sustained protection for its population. ## Learning and Looking Ahead: The Salima Review Meeting From December 8th to 12th, 2025, key stakeholders, including government officials, health experts, and international partners, convened in Salima, Malawi, for a comprehensive review of these critical public health interventions. This meeting was more than just a celebration of success; it was a vital opportunity for reflection and strategic planning. The participants meticulously validated coverage data, ensuring accuracy and transparency in reporting the achievements. Crucially, they also documented lessons learned from both the HPV and Mpox campaigns. Identifying what worked well and what could be improved is fundamental for continuous progress. The insights gained from the review meeting were then translated into actionable work plans designed to address any identified gaps and further strengthen Malawi's health systems for 2026 and beyond. This proactive approach to learning and adaptation ensures that future immunization efforts and outbreak responses will be even more efficient and impactful, solidifying Malawi's commitment to evidence-based public health policy and practice. ## A Beacon of Progress for Global Health Security Malawi's achievements in 2025 stand as a testament to its unwavering dedication to public health and its burgeoning capacity for rapid, data-driven outbreak response and integrated immunization strategies. The successful HPV vaccination campaign, reaching 91% of girls, and the exemplary 100% coverage in the Mpox outbreak response demonstrate the country's effective leadership, strong partnerships, and community engagement. These efforts are not only protecting the people of Malawi but also contributing significantly to regional and global health security goals. With continued investment from national and international partners, and a sustained collaborative spirit, Malawi is exceptionally well-positioned to build upon these gains. The nation is proving that even with resource constraints, strategic planning, robust implementation, and a commitment to learning can lead to profound improvements in population health, ensuring that vulnerable communities are protected and that the journey toward national and global health security goals continues to advance successfully.